太疯狂！有人“一年花10万”“房子打没一套”，只为做这一件事

Core Viewpoint - The article discusses the rising anxiety among parents regarding their children's height, leading to increased demand for growth hormone treatments, despite many children not meeting the criteria for such interventions [4][7][22]. Group 1: Market Dynamics - The market for growth hormones is experiencing significant demand, with parents willing to spend substantial amounts, such as 100,000 yuan annually, to ensure their children achieve desired heights [9][6]. - The sales distribution of growth hormones shows that over 70% of sales occur in private medical institutions, with a growing trend towards this channel as public hospitals' reliance decreases [11]. - Companies like Changchun High-tech and its subsidiary, Jinsai Pharmaceutical, reported substantial revenues, with Jinsai achieving 5.152 billion yuan in revenue in the first half of 2024, reflecting a 0.25% year-on-year growth [11]. Group 2: Clinical Insights - Clinical observations indicate that less than 20% of children seeking treatment actually require growth hormone therapy, highlighting a disconnect between parental anxiety and medical necessity [7][20]. - The use of growth hormones can lead to significant side effects, including metabolic disorders and potential diabetes, especially when used inappropriately [21][22]. - Medical professionals emphasize the importance of thorough assessments before initiating treatment, including monitoring growth rates and overall health indicators [20][22]. Group 3: Technological and Treatment Innovations - Future developments in the growth hormone market are expected to focus on innovative delivery methods, expanding indications beyond pediatric growth hormone deficiency, and optimizing existing long-acting technologies [14][21]. - The article mentions various technical paths for long-acting growth hormones, including PEGylation and protein fusion technologies, which could enhance product competitiveness [14][21]. Group 4: Consumer Behavior and Marketing Strategies - Private medical institutions are capitalizing on parental anxiety through promotional strategies, such as low-cost check-ups, which may lead to unnecessary treatments [15]. - There is a noted trend of parents seeking growth hormones through informal channels, often at discounted prices, raising concerns about the safety and appropriateness of such practices [17].